Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

GF52166943

Samarium

foil, not light tested, 25x25mm, thickness 0.005mm, as rolled, 99%

Synonym(s):

Samarium, SM000205

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Empirical Formula (Hill Notation):
Sm
CAS Number:
7440-19-9
Molecular Weight:
150.36
MDL number:
MFCD00011233
UNSPSC Code:
12141612
PubChem Substance ID:
329807881
NACRES:
NA.23

Assay

99%

form

foil

manufacturer/tradename

Goodfellow 521-669-43

resistivity

91.4 μΩ-cm, 0°C

size × thickness

25x25 mm × 0.005 mm

bp

1794 °C (lit.)

mp

1074 °C (lit.)

density

7.47 g/mL at 25 °C (lit.)

SMILES string

[Sm]

InChI

1S/Sm

InChI key

KZUNJOHGWZRPMI-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

Pictograms

Flame
GHS02

Signal Word

Warning

Hazard Statements

H261

Hazard Classifications

Water-react 3

Storage Class Code

4.3 - Hazardous materials which set free flammable gases upon contact with water

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Samarium(II)-iodide-mediated cyclizations in natural product synthesis.
David J Edmonds et al.
Chemical reviews, 104(7), 3371-3404 (2004-07-15)
Pete Anderson et al.
Expert review of anticancer therapy, 7(11), 1517-1527 (2007-11-21)
Radiation therapy can be an effective means to treat bone metastases, which occur in more than 50% of cancer patients. (153)Samarium lexidronam ((153)Sm-EDTMP; Quadramet, Cytogen) is a radiopharmaceutical designed for deposition into bone metastases. Bone scans can identify patients that
Michal Szostak et al.
Chemical communications (Cambridge, England), 48(3), 330-346 (2011-09-01)
Samarium diiodide (SmI(2)) is one of the most important reductive electron transfer reagents available in the laboratory. Key to the popularity of SmI(2) is the ability of additives and co-solvents to tune the properties of the reagent. Over the last
Jose M Concellón et al.
Chemical Society reviews, 33(9), 599-609 (2004-12-14)
The development of methodologies for the formation of carbon-carbon double bonds could be considered one of the most important challenges in organic synthesis. To this end, beta-elimination reactions in 1,2-difunctionalised substrates have been one of the most important means of
A N Serafini
Cancer, 88(12 Suppl), 2934-2939 (2000-07-18)
In patients with bone pain due to metastatic disease, intravenous systemic radioisotope therapy may be a useful adjunct to other methods for palliating pain. Various studies have been performed utilizing a short-lived radioisotope conjugated to a tetraphosphonate (samarium 153 lexidronam)
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service